Introduction {#sec1}
============

Liver regeneration after the loss of hepatic tissue is a fundamental liver response to injury \[[@cit0001]\]. In the rat the removal of median and left lateral lobes (about 70% of liver mass) results in the organ rebuilding within 7-10 days \[[@cit0002]\]. In this commonly used rat model of partial hepatectomy (PH) hepatocytes divide first at about 24 h after hepatectomy, followed by the biliary ductular cells, then the Kupffer cells and stellate cells, and finally the endothelial cells \[[@cit0001], [@cit0003]\]. This highly coordinated process is regulated by three main types of pathways, including cytokines and growth factors, changes in enzymes and proteins related to the extracellular matrix (ECM), and metabolic networks that link liver function with cell growth and proliferation \[[@cit0003], [@cit0004]\]. In the set of growth factors the hepatocyte growth factor (HGF) and epidermal growth factor (EGF) appear to play important roles in this process \[[@cit0001], [@cit0005]\]. Hepatocyte growth factor, up-regulated in response to liver injury, acts as a ligand of the c-*Met* proto-oncogene product, which is expressed not only on hepatocytes but also on endothelial and epithelial cells \[[@cit0006]\]. Epidermal growth factor acts via epidermal growth factor receptor (EGFR), inducing DNA synthesis in rat hepatocytes \[[@cit0007], [@cit0008]\]. Both c-met and EGFR are transmembrane tyrosine kinases, which while interacting with their ligands start the cascade of phosphorylations resulting in the activation of transcription factors \[[@cit0004], [@cit0009]\]. The role of HGF and EGF in the priming and early stage of liver regeneration is well established \[[@cit0003]--[@cit0005]\], but it is not clear whether their activity is also important in later phases of that organ's rebuilding, especially upon the influence of factors with anti-proliferative potential.

Type I interferons are pleiotropic cytokines identified over 50 years ago, and it is stated that they inhibit the transcription and/or translation of a number of RNA and DNA viruses, as well as the growth and proliferation of a variety of cell types \[[@cit0010], [@cit0011]\]. Interacting with their specific receptor they activate classical JAK (Janus kinase)--STAT (signal transducer and activator of transcription) signaling pathways and regulate, either directly or indirectly, several other downstream cascades \[[@cit0012]\].

According to our best knowledge, the influence of IFN-α on growth factors, namely HGF and EGF, during late stages of rat liver regeneration has not been explored. We used a PH-induced liver regeneration rat model to investigate the influence of IFN-α administration on expression of the *HGF* and *EGF* genes together with the concentrations of HGF and EGF molecules in liver tissue until 120 h after surgery.

Material and methods {#sec2}
====================

The 40 three-month-old male Wistar rats were maintained on rat chow and water under standard conditions. Animals were randomly assigned to groups of 20 rats each. The animals of the first group (IFN/H) were injected subcutaneously with 0.5 ml of IFNα-2b (Intron A, Shering-Plough, 5 MU/100 ml 0.9% NaCl). 24 h later the 3/4 (70%) partial hepatectomy was performed according to Higgins and Anderson under anesthesia (ketamine intraperitoneally, 50 mg/kg) by removing the median and left lateral lobes \[[@cit0002]\]. After the next 24 h the second IFNα-2b dose was administered. A similar schedule was applied in the next group injected with 0.5 ml of 0.9% NaCl (NaCl/H, control group). Rats were sacrificed in groups of five at 48 h, 72 h, 96 h and 120 h after surgery. Injections and surgical procedures were carried out between 9.00 and 11.00 a.m. to minimize the influence of circadian variations. Excised livers samples (in IFN/H and NaCl/H groups, obtained during hepatectomy, marked "1"), and restituted liver mass (in IFN/H and NaCl/H groups, obtained during autopsy, marked "2") were divided into two separate portions and stored at --80°C. The experiment schedule is shown in [Figure 1](#f0001){ref-type="fig"}.

![Schedule of animal experiment](CEH-3-29250-g001){#f0001}

The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki, as reflected by the *a priori* approval (no. 1/02; 19.02.2002) of the Local Ethics Commission for Animal Experiments of the Medical University of Silesia.

Total RNA was isolated from 80 mg of tissue samples using the RNeasy Midi Kit (Qiagen, Germany). In addition to the standard procedure, DNase I (Qiagen, Germany) was used to remove trace amounts of genomic DNA. RNA were quantified by measuring the absorbance at 260 and 280 nm and the integrity was assessed by electrophoresis in ethidium bromide stained 1.2% agarose gel. RNA isolates were used for cDNA synthesis by RT reaction. 1 μg of total RNA was reverse transcribed into cDNA in a total volume of 100 μl using the High-Capacity cDNA Archive Kit (Applied Biosystems, USA) according to the manufacturer's instructions. Obtained cDNA was used to determine *HGF* and *EGF* gene expression levels by quantitative real-time PCR assay (TaqMan system). TaqMan primers and probes for HGF and EGF were bought as ready to use TaqMan Gene Expression Assays (Rn 00566673_m1 and Rn 00563336_m1, respectively) and for the housekeeping gene -- GAPDH Endogenous Control (FAM/MGB Probe, Primer Limited, Rn 99999916_s1) (Applied Biosystems, USA). Q-PCR for both genes was performed in a volume of 20 μl on the ABI PRISM 7300 Real Time PCR Detection System (Applied Biosystems, USA). For each run, a Q-PCR mix was prepared on ice containing 10 μl of Applied Biosystems Universal PCR Master Mix, 1 μl of primers and probe mix and 8 μl of H~2~O (Qiagen, Germany). To each well of a 96-well plate, 19 μl of Q-PCR mix and 1 μl of cDNA samples were added. All PCRs were performed in triplicate. In all amplification reactions, a negative control was also included. Thermal cycling for *HGF*, *EGF* and *GAPDH* genes was initiated with an incubation step at 50°C for 2 minutes, followed by a first denaturation step at 95°C for 10 minutes, and continued with 40 cycles of 95°C for 15 seconds, 60°C for 1 minute. The standard curves for the housekeeping gene *GAPDH* and the target genes were generated by serial dilutions of the control cDNA (equivalent to 1 μg of total RNA) in six 2-fold dilution steps. The expression levels of *HGF*, *EGF* and *GAPDH* genes in every sample were determined from the respective standard curve and the analyzed genes' expression was divided by the *GAPDH* gene expression to obtain a normalized target value (relative expression level).

Weighed samples of rat liver (100 mg) were homogenized using a PRO 200 homogenizer (PRO Scientific Inc, USA) at 10 000 RPM in nine volumes of phosphate-buffered saline solution (PBS without Ca and Mg, BIOMED, Poland) containing 0.5% Triton X-100 (Sigma-Aldrich, USA). Next homogenates were centrifuged at 12 000 RPM for 15 minutes at +4°C, and the supernatants were divided into appropriate portions and frozen at --80°C until required for further surveys. Total protein concentration in the liver tissue homogenates was determined with the Lowry method. In this method, the final color is of two reactions: first the biuret reaction with Cu^2+^ ions in an alkaline medium, then the second reaction reducing phosphomolybdic and phosphowolframic acid (Folin-Ciocalteu reagent) to the corresponding oxides by tyrosine and tryptophan present in the proteins \[[@cit0013]\]. Hepatocyte growth factor and EGF concentrations in the rat liver tissue homogenates were measured with ELISA methods using the HGF ELISA kit (cat. no. SEA047Ra Cloud -- Clone, USA) and EGF ELISA Kit (cat. no. SEA560Ra, Cloud -- Clone, USA) according to the manufacturer's instructions. The absorption values were read at 450 nm in a microplate reader (μQuant, BIO-TEK INSTRUMENTS, INC, USA) with KC Junior software (BIO-TEK, USA). Concentrations were estimated according to the respective standard curves, taking into account the 50-fold dilution of specimens. The results were calculated in pg/mg (ng/g) total protein concentration for every tissue sample (relative concentration). The measurements were conducted in duplicate, with estimated variation of 4.2-14.8% for HGF and 0.4-6.0% for EGF.

Data were analyzed using the Statistica 10.0 software pack. Descriptive statistics were calculated and data were tested for normality of distribution and homogeneity of variance. For differences between groups in the case of independent samples the analysis of variance and post hoc tests while for dependent variables *t* tests for dependent samples were used, with *p* \< 0.05 considered significant. The direction and strength of the dependence between quantitative variables was evaluated by use of the regression equation and linear correlation coefficient.

Results {#sec3}
=======

The schedule of our experiment allowed us to analyze the *HGF* and *EGF* expression together with HGF and EGF tissue concentrations in normal liver, the liver exposed to a single dose of IFNα-2b, normal regenerating liver tissue and the liver regenerating upon IFNα-2b influence at consecutive time points. Results of these analyses are presented in [Table 1](#t0001){ref-type="table"} -- according to HGF -- and [Table 2](#t0002){ref-type="table"} -- according to EGF. *HGF* expression was significantly different at 48 h after PH: it was higher in regenerating rat liver, both normal and exposed to IFNα-2b. This phenomenon had no further consequences in higher HGF concentration in liver tissue at any analyzed time points and conditions ([Table 1](#t0001){ref-type="table"}). In contrast, *EGF* expression was not significantly different in liver exposed to IFNα-2b influence, but it was higher in normal liver compared with regenerating tissue only at 120 h after PH. No changes in EGF liver tissue concentrations were noted ([Table 2](#t0002){ref-type="table"}). Because HGF and EGF concentrations were calculated based on liver tissue protein concentration, we analyzed this parameter in every study group, finding no differences ([Table 3](#t0003){ref-type="table"}).

###### 

Expression of *HGF* gene and concentration of HGF in normal and regenerating liver tissue upon IFNα-2b influence

  Group        *HGF/*GAPDH                   HGF \[ng/g\]                                                                                                 
  ------------ ----------------------------- ----------------------------------- ------ ----------------------------- ----------------------------------- ------
  IFN/H/48     1.04 ± 0.35                   2.71 ± 0.40                         0.02   828.41 ± 87.70                865.71 ± 230.18                     0.71
  IFN/H/72     1.16 ± 1.52                   1.49 ± 1.78                         0.06   775.72 ± 35.86                1095.67 ± 214.56                    0.24
  IFN/H/96     0.37 ± 0.14                   1.98 ± 0.71                         0.07   874.96 ± 186.56               576.65 ± 21.83                      0.09
  IFN/H/120    1.97 ± 2.99                   5.90 ± 7.13                         0.16   737.46 ± 91.57                676.70 ± 45.26                      0.20
               **Normal liver -- control**   **Regenerating liver -- control**          **Normal liver -- control**   **Regenerating liver -- control**   
  NaCl/H/48    0.50 ± 0.44                   3.83 ± 0.60                         0.02   781.71 ± 8.45                 607.09 ± 427.35                     0.67
  NaCl/H/72    0.06 ± 0.04                   1.83 ± 2.48                         0.50   700.95 ± 60.28                726.39 ± 79.18                      0.32
  NaCl/H/96    0.34 ± 0.05                   4.44 ± 3.46                         0.18   829.87 ± 235.55               768.26 ± 40.61                      0.65
  NaCl/H/120   3.10 ± 1.37                   3.16 ± 2.10                         0.92   735.05 ± 52.72                569.89 ± 206.75                     0.10

"1" -- liver tissues removed during partial hepatectomy

"2" -- regenerating liver mass obtained during autopsy at consecutive time points

###### 

Expression of *EGF* gene and concentration of EGF in normal and regenerating liver tissue upon IFNα-2b influence

  Group        *EGF/*GAPDH                   EGF \[ng/g\]                                                                                                  
  ------------ ----------------------------- ----------------------------------- ------- ----------------------------- ----------------------------------- ------
  IFN/H/48     4.33 ± 1.39                   3.08 ± 1.87                         0.41    654.96 ± 85.79                488.98 ± 94.86                      0.05
  IFN/H/72     1.27 ± 2.18                   2.31 ± 3.25                         0.99    686.97 ± 92.76                741.09 ± 95.59                      0.02
  IFN/H/96     1.11 ± 1.06                   6.11 ± 9.61                         0.98    771.59 ± 130.58               413.71 ± 15.86                      0.03
  IFN/H/120    0.55 ± 0.17                   2.32 ± 2.26                         0.13    585.46 ± 88.13                507.2 ± 30.32                       0.08
               **Normal liver -- control**   **Regenerating liver -- control**           **Normal liver -- control**   **Regenerating liver -- control**   
  NaCl/H/48    2.78 ± 3.52                   9.08 ± 3.74                         0.22    549.12 ± 94.16                507.02 ± 455.96                     0.94
  NaCl/H/72    1.43 ± 0.80                   3.19 ± 1.05                         0.13    613.22 ± 95.59                483.13 ± 70.26                      0.11
  NaCl/H/96    0.82 ± 0.10                   1.26 ± 1.15                         0.60    554.16 ± 175.21               596.44 ± 59.49                      0.65
  NaCl/H/120   4.76 ± 2.25                   2.37 ± 1.65                         0.006   748.90 ± 52.52                563.56 ± 203.05                     0.07

"1" -- liver tissues removed during partial hepatectomy

"2" -- regenerating liver mass obtained during autopsy at consecutive time points

###### 

Protein concentration in the liver tissue specimens obtained during experiment

  Group        Total liver tissue protein \[g/l\]                                       
  ------------ ------------------------------------ ----------------------------------- ------
  IFN/H/48     16.30 ± 2.29                         13.60 ± 0.57                        0.10
  IFN/H/72     16.28 ± 1.88                         14.20 ± 1.41                        0.89
  IFN/H/96     14.60 ± 0.84                         14.83 ± 2.15                        0.98
  IFN/H/120    16.72 ± 1.70                         16.58 ± 1.00                        0.83
               **Normal liver -- control**          **Regenerating liver -- control**   
  NaCl/H/48    17.10 ± 1.18                         14.30 ± 1.56                        0.33
  NaCl/H/72    16.50 ± 1.18                         14.33 ± 0.45                        0.15
  NaCl/H/96    16.82 ± 1.43                         15.83 ± 0.15                        0.81
  NaCl/H/120   17.26 ± 2.47                         14.94 ± 1.92                        0.10

"1" -- liver tissues removed during partial hepatectomy

"2" -- regenerating liver mass obtained during autopsy at consecutive time points

The correlation between *HGF* and *EGF* expression was significant in normal liver tissue ([Fig. 2](#f0002){ref-type="fig"}) and upon the impact of a single dose of IFNα-2b ([Fig. 3](#f0003){ref-type="fig"}). Despite these results, no correlations between HGF and EGF concentrations in normal or regenerating liver were observed. Similarly, there were no significant correlations between *HGF* expression and HGF concentration as well as *EGF* expression and EGF concentration in regenerating liver tissue, and no influence of IFNα-2b was observed (data not shown).

![Correlation between *HGF* and EGF expression in normal liver tissue (*r* = 0.713, *p* = 0.001)](CEH-3-29250-g002){#f0002}

![Correlation between *HGF* and EGF expression in liver tissue exposed to a single dose of IFN-α (*r* = 0.52, *p* = 0.038)](CEH-3-29250-g003){#f0003}

Discussion {#sec4}
==========

The nature of the lost liver tissue rebuilding, compensatory hyperplasia rather than true regeneration, has been explored for many years, but many aspects of this phenomenon are poorly understood \[[@cit0014], [@cit0015]\]. The process of hepatocyte repopulation is accomplished by a sequence of distinct phases: an initiation phase, rendering cells in a state of replicative competence; a proliferation phase, where expansion of the cell population occurs; and a termination phase, where cell growth is suppressed to terminate regeneration at a set point \[[@cit0016], [@cit0017]\]. In our experimental model we collected regenerating liver tissue at 48 h, 72 h, 96 h and 120 h, i.e. we focused on proliferation and early termination phases. Administration of the first IFNα-2b dose 24 hours before PH created the possibility of its influence on molecular phenomena during the initiation phase. Hepatocyte growth factor and EGF, the complete mitogens for hepatocytes, are proven to play a role mainly in the initiation phase of liver regeneration \[[@cit0001], [@cit0003], [@cit0008], [@cit0018]\]. However, HGF is synthesized and excreted by mesenchymal cells diffused over the organs and tissues as a single-chain polypeptide and deposited in the ECM of the liver as an inactive precursor \[[@cit0019], [@cit0020]\]. In basal conditions *HGF* mRNA and HGF are present in small amounts in liver tissue, but the early phenomenon just after injury is the release of HGF from ECM deposits and forming its active, double-chain molecule \[[@cit0021], [@cit0022]\] and then higher expression of *HGF* in the remnant liver \[[@cit0023], [@cit0024]\]. In our experiment IFNα-2b was administered twice, the first dose 24 hours before PH -- which could reduce protein synthesis in resting hepatocytes and non-parenchymal liver cells and negatively regulate the priming phase, resulting in delayed regeneration as in the experiment by Nishiguchi *et al*. \[[@cit0025]\]. Theocharis *et al*. administered IFNα-2b either 2 or 12 h postoperatively, and inhibition of hepatocyte proliferation was observed at 24 h postoperatively, while at further time intervals up to 48 h DNA synthesis remained similar to that observed in the control group \[[@cit0026]\]. It could suggest that IFNα-2b-influenced inhibition of regeneration progress lasts around 24-48 h; in our experiment we started analyses at 48 h after PH and 24 h after the second dose of IFNα-2b. Moreover, in rats after a first peak of hepatocyte DNA synthesis, around 24 h after PH a second smaller peak is detected between 36 and 48 h \[[@cit0001]\] -- the time after surgery when IFNα-2b administered 24 h after PH could modulate the proliferative phase of regeneration. Li *et al*. used the Rat Genome 230 2.0 Array to determine the expression changes of genes responsible for hepatocyte G0/G1 transition during rat liver regeneration and concluded that the HGF, IL-10, IL-6 and JAK/STAT signaling pathways play a major role \[[@cit0027]\]. In our study *HGF* expression was still significantly higher at 48 h in simply hepatectomized rats and in regenerating liver upon IFNα-2b influence, while no differences were observed in later stages in both groups. The possible explanations are that the administered dose of IFNα-2b was not high enough for *HGF* expression inhibition or this result reflects the importance of restoring tissue deposits of *HGF* mRNA in regenerating liver. The liver tissue concentrations of HGF showed no differences at any time point in either experimental group. It could suggest that during liver regeneration the amount of HGF molecules is rather stable in the 48-120 h period of time and IFNα-2b administration does not influence this status. Unfortunately, the ELISA method does not allow one to distinguish the inactive form of HGF bound in ECM from the biologically active double-chain molecule. It is possible that during regeneration these two forms remain in a dynamic balance in the tissue environment, but this idea needs to be proven.

The experimental data on EGF expression during rat liver regeneration are not unequivocal.

Haber *et al*. reported undetectable *EGF* and *EGFR* gene expression during the immediate-early phase of rat liver regeneration \[[@cit0028]\]. On the other hand, a rapid increase of *EGF* mRNA in the immediate-early phase of liver regeneration was also proven \[[@cit0009]\]. Recent published data of NF-κB signaling pathway-related gene analyses based on the Rat Genome 230 2.0 array made by Chang *et al*. revealed *EGF* in the group of genes significantly under-expressed at 12 and 30 h, but there was no differences in its expression during the period of 36-168 hours of liver regeneration. In the same experiment *HGF* expression was significantly higher at 6 h, 24 h and 30 h, but once more its expression was significant at 72 h \[[@cit0029]\]. The observation connected with *EGF* expression dynamics is consistent with our results only until 96 h, but in our experiment at 120 h *EGF* expression was significantly higher in normal than in regenerating liver but not in tissue exposed to IFNα-2b before. Moreover, their experiment was performed using hepatocytes isolated from regenerating rat livers, while in our study *HGF* and *EGF* gene expression was analyzed in tissue samples, where it could be modified by the cellular milieu; moreover, for both factors not only hepatocytes are their important source. Our results of low, but significantly correlated *HGF* and *EGF* expression in normal liver tissue seems to be in concordance with observations reported previously \[[@cit0001], [@cit0003]--[@cit0005]\]. This correlation also exists in liver tissue exposed to one dose of IFNα-2b, but not in later steps of liver regeneration irrespectively of its influence or absence. We tried to established whether these two growth factors have been importantly changing during later stages of liver regeneration at both the mRNA and molecular levels and whether IFNα-2b administration will change it -- and if so, when. Based on our results, we conclude that HGF and EGF are not significantly involved in later stages of liver regeneration, and IFNα-2b does not impact their activity in these circumstances.

Conclusions {#sec5}
===========

Hepatocyte growth factor and EGF are not significantly involved in regulation of later stages of rat liver regeneration. IFNα-2b does not impact expression of their genes or the presence of these growth factor molecules in regenerating liver tissue.
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